AACE Annual Meeting 2026 On-Demand

AACE Annual Meeting 2026 On-Demand – Videos + Subtitles | Endocrinology CME Course 2026

AACE Annual Meeting 2026 On-Demand | Endocrinology, Diabetes, Obesity, Thyroid, Bone, Pituitary, Adrenal & Cardiometabolic Medicine | Videos + Subtitles

The AACE Annual Meeting 2026 On-Demand provides an extensive update across modern clinical endocrinology, diabetes and diabetes technology, obesity medicine, thyroid disease, metabolic bone disease, cardiometabolic medicine, lipid disorders, pituitary disease, adrenal disorders, reproductive endocrinology, and emerging endocrine technologies.

Recorded from the American Association of Clinical Endocrinology (AACE) Annual Meeting 2026, held at Caesars Forum in Las Vegas, Nevada, the educational program brings together leading endocrinologists, researchers, and healthcare professionals to discuss current evidence, evolving clinical guidance, emerging therapies, and new technologies affecting endocrine practice.

The 2026 meeting featured more than 75 educational sessions spanning the major areas of clinical endocrinology, with special emphasis on nutrition, obesity, diabetes technology, GLP-1-based therapies, artificial intelligence, cardiometabolic health, thyroid disease, osteoporosis, and complex pituitary and adrenal disorders.

This MedicalAmboss edition provides the recorded educational content in a convenient offline format.

Course Details

• Course: AACE Annual Meeting 2026 On-Demand
• Provider: American Association of Clinical Endocrinology (AACE)
• Live Meeting Dates: April 22–24, 2026
• Location: Caesars Forum, Las Vegas, Nevada
• Official On-Demand Start: June 1, 2026
• Official On-Demand Expiration: April 30, 2027
• MedicalAmboss Format: Videos + Subtitles
• PDFs: Not Included
• Slides: Not Included
• Primary Specialty: Endocrinology
• Meeting Format: Multidisciplinary Clinical and Scientific Endocrinology Education
• Official AACE On-Demand Credit: Up to 47.25 CME/CE/MOC credits for eligible official participants

What Is Included in This MedicalAmboss Package?

This package contains:

• High-Quality Recorded Video Lectures
• Subtitles
• Multiple AACE Annual Meeting 2026 scientific and clinical sessions
• Offline educational access
• Self-paced study

Important

No PDFs or presentation slide files are included with this course.

The package is designed specifically for learners who want to watch and review the recorded lectures.

Official AACE Annual Meeting 2026

The AACE Annual Meeting 2026 brought together the clinical endocrinology community to review recent scientific discoveries, clinical advances, new therapies, evolving guidelines, and technologies affecting endocrine care.

The official conference tracks included:

• Diabetes and Diabetes Technology
• Bone and Parathyroid
• Thyroid and Thyroid Procedures
• Cardiometabolic and Lipids Management
• Nutrition and Obesity
• Pituitary, Adrenal, Gonad and Neuroendocrine
• Professional Development
• Artificial Intelligence

AACE described the meeting as more than 75 educational sessions focused on practical endocrine care and emerging science.

Target Audience

The AACE Annual Meeting 2026 On-Demand is relevant for healthcare professionals at all stages of endocrine training and practice, including:

• Endocrinologists
• Diabetologists
• Internal Medicine Physicians
• Primary Care Physicians
• Obesity Medicine Specialists
• Lipid Specialists
• Endocrine Surgeons
• Physician Assistants
• Nurse Practitioners
• Nurses
• Pharmacists
• Registered Dietitians
• Diabetes Educators
• Medical Students
• Residents
• Endocrinology Fellows
• Researchers in Endocrinology and Metabolism

AACE officially identifies clinical endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, registered dietitians, medical students, residents, and fellows as the target audience for the on-demand activity.

Program Overview

Clinical endocrinology is changing rapidly.

New medications, devices, biomarkers, diagnostic techniques, artificial intelligence systems, and clinical guidelines are influencing the way endocrine disorders are diagnosed and managed.

The AACE Annual Meeting 2026 addresses these developments through a broad multidisciplinary program focused on:

• Diabetes
• Diabetes technology
• Obesity
• Nutrition
• Thyroid disease
• Thyroid cancer
• Osteoporosis
• Metabolic bone disease
• Parathyroid disease
• Pituitary disorders
• Adrenal disorders
• Reproductive endocrinology
• Cardiovascular risk
• Lipid disorders
• MASLD and MASH
• Artificial intelligence
• Endocrine practice management

The program emphasizes practical translation of new evidence into patient care.

Learning Objectives

By the end of the educational activity, learners should be able to:

• Discuss recent scientific and clinical discoveries in endocrinology, diabetes, and metabolism.
• Apply newly acquired knowledge to diagnosis and clinical management to improve patient outcomes.
• Assess the potential applications of emerging scientific advances affecting endocrine practice.
• Educate patients regarding available clinical treatment options.
• Recognize new technologies and therapeutic approaches influencing endocrine care.
• Apply contemporary approaches to diabetes, obesity, thyroid, metabolic bone, pituitary, adrenal, and cardiometabolic disorders.

The first four objectives correspond directly to the official AACE Annual Meeting 2026 On-Demand learning objectives.

Bone and Parathyroid

The 2026 program includes extensive coverage of osteoporosis, metabolic bone disorders, chronic kidney disease-related bone disease, and parathyroid disorders.

CKD-Related Metabolic Bone Disease

Reviews the complex relationship between chronic kidney disease, mineral metabolism, bone turnover, and fracture risk.

Clinical considerations include:

• Calcium balance
• Phosphate regulation
• Vitamin D
• Parathyroid hormone
• Bone turnover
• Renal osteodystrophy

Hypoparathyroidism: Diagnosis and Management – What the Guidelines Tell Us

Reviews contemporary diagnostic and treatment approaches to hypoparathyroidism.

Topics may include:

• Calcium management
• Vitamin D therapy
• PTH replacement
• Biochemical monitoring
• Chronic complications
• Guideline-based management

Hormone Therapy in the Prevention and Treatment of Osteoporosis

Examines the role of hormonal therapy in maintaining skeletal health and reducing fracture risk in appropriate patients.

Anabolic First or Bisphosphonate First? Rethinking the Initial Approach to Treatment

Addresses an important clinical question in modern osteoporosis care:

Should patients at very high fracture risk begin with an anabolic agent rather than traditional antiresorptive treatment?

The session considers:

• Fracture risk
• Treatment sequencing
• Anabolic therapies
• Bisphosphonates
• Long-term skeletal outcomes

Nutrition and Skeletal Health

Explores how nutrition affects bone formation, remodeling, and fracture prevention.

Rare Bone Disorders: Primer for Diagnosis and Treatment

Reviews uncommon metabolic and genetic bone disorders encountered in endocrine practice.

DSN Year in Review – Bone

Provides an update on major developments in bone and mineral metabolism from the preceding year.

Diabetes & Diabetes Technology

Diabetes is one of the most extensive areas of the AACE Annual Meeting.

The 2026 program examines both pharmacologic therapy and rapidly advancing diabetes technology.

AACE 2026 Algorithm for Management of Adults with Type 2 Diabetes

Reviews the latest AACE approach to individualized management of adults with type 2 diabetes.

Clinical decision-making may incorporate:

• Glycemic control
• Cardiovascular disease
• Chronic kidney disease
• Obesity
• Hypoglycemia risk
• Weight management
• Medication selection
• Patient preferences

Global Perspectives on Diabetes and Obesity

Examines diabetes and obesity from an international perspective, including differences in prevalence, access, treatment, and population-specific risk.

Cell Therapies in T1DM – Are We Close to a Cure?

Explores emerging cellular therapies for type 1 diabetes.

Areas of interest include:

• Islet replacement
• Stem-cell-derived therapies
• Immune protection
• Insulin independence
• Future therapeutic possibilities

Continuous Ketone Monitoring

Examines emerging technology designed to provide ongoing ketone measurements and its potential clinical applications.

Insulin Pumps for Type 2 Diabetes

Reviews the expanding use of insulin pump technology in patients with type 2 diabetes.

CGM for Gestational Diabetes

Examines the potential role of Continuous Glucose Monitoring (CGM) in pregnancy complicated by diabetes.

Perioperative Management of CGM and Automated Insulin Delivery Systems

Addresses management of increasingly common diabetes technologies in patients undergoing surgery.

Topics include:

• CGM
• Insulin pumps
• Automated insulin delivery
• Perioperative glucose monitoring
• Device safety

AI’s Transformation in Diabetes Care

Explores how artificial intelligence may influence:

• Glucose data interpretation
• Predictive analytics
• Personalized treatment
• Diabetes devices
• Clinical workflow
• Decision support

Atypical Diabetes: PTD and CFRD

Reviews less common diabetes phenotypes and complex diagnostic scenarios.

Weekly Insulin – Pros and Cons

Examines the potential advantages and limitations of ultra-long-acting weekly insulin formulations.

Early-Stage Type 1 Diabetes: Screening, Monitoring and Treatment

Reviews the emerging clinical model of identifying type 1 diabetes before symptomatic hyperglycemia occurs.

This was also the topic of the Alan J. Garber, MD, PhD, MACE Lectureship, presented by Linda DiMeglio, MD, MPH during the 2026 meeting.

Advances in Prediabetes and Diabetes Prevention

Reviews evolving approaches to preventing or delaying diabetes progression.

Thyroid

The AACE 2026 thyroid program covers both common thyroid disease and complex endocrine oncology.

Nutrition and Thyroid Health

Explores relationships between dietary factors, iodine intake, micronutrients, and thyroid physiology.

Updates to Thyroid Nodules and Cancer Guidelines

Reviews evolving guidance surrounding:

• Thyroid nodules
• Risk stratification
• Imaging
• Biopsy
• Molecular testing
• Thyroid cancer
• Surveillance
• Treatment

Iodine, Thyroid Autoimmunity, Goiter and Oncogenesis

Examines the relationship between iodine exposure, autoimmune thyroid disease, goiter, and thyroid tumor biology.

Minimally Invasive Management of Thyroid Nodules

Reviews nonsurgical and minimally invasive approaches to selected thyroid nodules.

Optimal Thyroid Hormone Replacement in Thyroid Cancer

Examines individualized thyroid hormone management following thyroid cancer treatment.

Challenging Benign and Malignant Thyroid Cases

Case-based discussion of difficult thyroid disorders requiring nuanced diagnostic and therapeutic decision-making.

Drug-Induced Thyroid Dysfunction

Reviews medications capable of producing:

• Hypothyroidism
• Hyperthyroidism
• Thyroiditis
• Abnormal laboratory testing

DSN Year in Review – Thyroid

Summarizes important developments in thyroid medicine.

Deconstructing the TSH Feedback Loop

Integrating Deiodinase Biology into the Management of Hypothyroidism

Presented by Antonio C. Bianco, MD, PhD, this was the Kahn-Tan-Faiman Frontiers in Science and Endocrinology Lectureship at AACE 2026.

The presentation examines:

• TSH physiology
• Deiodinase biology
• T4-to-T3 conversion
• Individual variation in thyroid hormone metabolism
• Implications for hypothyroidism management

Cardiovascular, Cardiometabolic & Lipids

Endocrine disease and cardiovascular risk are increasingly managed together.

Lp(a): What Every Endocrinologist Needs to Know

Reviews lipoprotein(a) as an important genetically influenced cardiovascular risk factor.

Topics include:

• Measurement
• Risk assessment
• Interpretation
• Cardiovascular implications
• Emerging therapies

Cardiovascular Risk Management in Type 1 Diabetes

Examines strategies to reduce long-term cardiovascular risk among patients with type 1 diabetes.

Cardiometabolic Risk in South Asians

Reviews population-specific metabolic and cardiovascular risk factors affecting South Asian patients.

MASLD and MASH

Explores metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Topics may include:

• Obesity
• Diabetes
• Insulin resistance
• Fibrosis assessment
• Cardiometabolic risk
• Multidisciplinary management

Optimizing Dyslipidemia Management

Reviews contemporary lipid-lowering strategies and individualized cardiovascular risk management.

Application of the AACE Algorithm to Patient Care

Translates current clinical guidance into practical patient-management decisions.

Multidisciplinary Management of MASLD and MASH

Explores collaboration between:

• Endocrinologists
• Hepatologists
• Primary care clinicians
• Obesity specialists
• Nutrition professionals

Pituitary, Gonad, Adrenal & Neuroendocrine

The program also addresses complex hormonal disorders requiring specialist endocrine management.

Functional Hypogonadism

Reviews evaluation and treatment of functional causes of testosterone or gonadal hormone deficiency.

Personalized Treatments for Acromegaly

Explores individualized therapy according to biochemical response, tumor characteristics, symptoms, and patient factors.

Hyperaldosteronism Screening and Management

Reviews:

• Screening criteria
• Aldosterone-renin testing
• Confirmatory testing
• Imaging
• Adrenal venous sampling
• Medical treatment
• Surgical management

Evaluation of Suspected Pheochromocytoma

Examines diagnostic approaches to catecholamine-producing tumors.

DSN Year in Review – PGAN

Reviews recent developments involving:

• Pituitary
• Gonadal
• Adrenal
• Neuroendocrine disorders

PCOS: An Evidence-Based Approach to Comprehensive Management in 2026

Reviews multidisciplinary management of polycystic ovary syndrome.

Major considerations include:

• Menstrual dysfunction
• Hyperandrogenism
• Fertility
• Metabolic disease
• Weight management
• Diabetes risk
• Cardiovascular risk

Pituitary Masses Requiring Surgery

Explores indications for surgical management of pituitary lesions.

Pre- and Postoperative Endocrine Considerations

Reviews endocrine management surrounding pituitary and other endocrine surgery.

The Indeterminate Adrenal Mass

Addresses challenging adrenal incidentalomas where imaging or biochemical results do not immediately establish diagnosis.

Obesity & Nutrition

Nutrition was a major theme of AACE 2026, with AACE emphasizing its role as a cornerstone of chronic endocrine and cardiometabolic disease prevention and treatment.

Should We Continue to Use BMI When Talking About Obesity?

Examines the strengths and limitations of Body Mass Index as a measure of adiposity and obesity-related risk.

The Do’s and Don’ts of Microdosing GLP-1 RA

Reviews clinical questions surrounding low-dose or nonstandard dosing strategies for GLP-1 receptor agonists.

Nutrition and Chronic Disease

Explores dietary approaches relevant to:

• Obesity
• Diabetes
• Cardiovascular disease
• Metabolic health
• Chronic endocrine conditions

Menopause, Metabolism and Weight

Reviews metabolic and body-composition changes occurring around menopause.

GLP-1 Use in Type 1 Diabetes and Obesity

Examines evolving evidence regarding GLP-1 receptor agonist use in patients with type 1 diabetes who also have obesity.

Pediatric Obesity

Reviews modern approaches to childhood and adolescent obesity.

DSN Year in Review – Nutrition & Obesity

Summarizes important clinical and scientific developments in obesity medicine and nutrition.

Exercise and Nutrition for Patients Taking GLP-1 RA/GIP Agents

Addresses practical management of patients receiving incretin-based anti-obesity medications.

Areas include:

• Nutrition
• Protein intake
• Exercise
• Lean mass
• Weight loss
• Treatment tolerance

Strategies to Decrease Sarcopenia

Examines approaches to preserving muscle mass and function, particularly during weight loss and aging.

Obesity Management Across Solid Organ Transplantation

Reviews obesity treatment in patients undergoing or living with solid-organ transplantation.

Professional Development & Artificial Intelligence

AACE 2026 also addresses the changing way endocrinology practices operate.

Triaging Endocrine Referrals

Explores methods to prioritize endocrine referrals according to clinical urgency and specialist need.

EHR Optimization

Reviews approaches to improving electronic health record workflows.

Making AI Work for You: Practical Applications in the Endocrine Clinic

Examines realistic clinical applications of artificial intelligence.

Potential areas include:

• Documentation
• Decision support
• Patient education
• Data analysis
• Workflow automation
• Clinical efficiency

Advancing Endocrine Education

Focuses on methods for improving endocrine teaching and training.

Graduated Responsibility and Precision Learning

Explores contemporary approaches to medical education and competency development.

Major Topics Covered

• Endocrinology
• Diabetes Mellitus
• Type 1 Diabetes
• Type 2 Diabetes
• Diabetes Technology
• Continuous Glucose Monitoring
• Insulin Pumps
• Automated Insulin Delivery
• Artificial Intelligence in Diabetes
• Weekly Insulin
• Prediabetes
• Obesity
• Nutrition
• GLP-1 Receptor Agonists
• GIP Therapies
• Sarcopenia
• Thyroid Disease
• Thyroid Nodules
• Thyroid Cancer
• Hypothyroidism
• Thyroid Hormone Replacement
• Thyroid Autoimmunity
• Osteoporosis
• Metabolic Bone Disease
• Hypoparathyroidism
• CKD-Mineral Bone Disorder
• Lipid Disorders
• Lp(a)
• Cardiometabolic Disease
• MASLD
• MASH
• Pituitary Disease
• Acromegaly
• Hyperaldosteronism
• Pheochromocytoma
• Adrenal Masses
• PCOS
• Hypogonadism
• Neuroendocrinology
• Reproductive Endocrinology
• Artificial Intelligence in Endocrinology
• Endocrine Practice Management

Official AACE On-Demand Activity

The official AACE Annual Meeting 2026 On-Demand became available on June 1, 2026 and expires April 30, 2027.

AACE lists:

• 47.25 CME Credits
• 47.25 Nursing Credits
• 47.25 ABIM-MOC Points
• 6.25 ABOM Credits

for eligible recorded sessions and participants enrolled through the official AACE learning activity.

Important CME / MOC Notice

The CME and MOC amounts above refer to the official AACE On-Demand activity.

Purchasing the downloaded Videos + Subtitles package from this MedicalAmboss listing does not by itself enroll the purchaser in the official AACE CME activity and does not automatically provide CME, MOC, Nursing, or ABOM credit.

Official credit eligibility, completion requirements, evaluation, and certificate issuance are controlled by AACE.

Why This Course Is Relevant

Endocrinology is undergoing rapid change.

In a single year, clinicians may need to incorporate:

• New diabetes devices
• New incretin therapies
• Updated thyroid recommendations
• New approaches to osteoporosis
• Emerging lipid treatments
• Advances in metabolic liver disease
• Artificial intelligence
• New obesity treatment strategies
• Evolving approaches to endocrine tumors

The AACE Annual Meeting 2026 On-Demand brings these developments together within a broad clinical program.

It is particularly valuable for clinicians seeking a comprehensive 2026 endocrinology update rather than education focused on only one endocrine disorder.

Why Choose the On-Demand Version?

On-demand education allows learners to create their own schedule rather than following a fixed live conference timetable.

The recorded format makes it possible to:

• Pause difficult lectures
• Replay complex explanations
• Review selected subspecialty topics
• Return to sessions when needed
• Focus on relevant clinical areas
• Learn at an individual pace

The addition of subtitles can also improve usability when reviewing terminology-heavy endocrine lectures.

Important Product Format

This MedicalAmboss package contains:

Included

• Recorded Videos
• Subtitles

Not Included

• PDFs
• PowerPoint Slides
• Presentation Slide Files

This distinction is important because the product is specifically sold as a video-based offline educational package.

Short Description

<div style=”border:2px solid #1677b8;border-radius:10px;padding:16px;background:#f7fbfe;”>

AACE Annual Meeting 2026 On-Demand – Videos + Subtitles provides a comprehensive 2026 endocrinology update covering diabetes and diabetes technology, obesity, GLP-1 therapies, thyroid disease, thyroid cancer, osteoporosis, metabolic bone disease, cardiometabolic health, lipids, MASLD/MASH, pituitary and adrenal disorders, PCOS, reproductive endocrinology, nutrition and AI in endocrine practice. This MedicalAmboss package includes recorded videos with subtitles only — no PDFs or slides.